Olanzapine Completed Phase 4 Trials for Psychotic Disorder NOS Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00806234Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
NCT00932529Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting